Recently approved Publication date 17 Mar 26
TD2027ENDO
Resource description
The purpose of this Technical Document (TD), which constitutes an integral part of the International Standard for Laboratories (ISL) [1] is to harmonize the analysis and reporting of the blood (serum) Markers of human Growth Hormone (hGH) as part of the Endocrine Module of the Athlete Biological Passport (ABP) to uncover the Use of Prohibited Substances associated with hGH biological activity, namely recombinant hGH preparations, hGH secretagogues, hGH analogs and releasing factors, and Insulin-like Growth Factor-I (IGF-I).
In Force on 1 January 2027